EXCELLTHERA
Live / Registered — Registered (as of 08 Feb 2022)
What this means for you
Registered since 08 Feb 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88167461
- Registration number
- 6639560
- Mark type
- Stylized text
- Filed
- 24 Oct 2018
- Published for opposition
- 23 Apr 2019
- Registered
- 08 Feb 2022
- Attorney of record
- Ernest V. Linek
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations in the nature of stem cells solutions to enable stem cell expansion for therapeutic purposes, used in hematopoietic stem cell transplantation (HSCT) for patients with blood cancers; Bioengineering pharmaceutical solutions containing small molecules for use in expanding cells for therapeutic use to patients with blood cancers and other diseases
- Class 042 — Scientific and technological services: Medical and scientific research in the field of stem cells; medical laboratory research; medical and scientific research, namely, conducting pre-clinical and clinical trials for others
Owner
- ExcellThera Inc., Montreal, Quebec, CA
- ExcellThera Inc., Montreal, Quebec, CA
- ExcellThera Inc., Montreal, Quebec, CA
Prosecution history
- 08 Feb 2022 — REGISTERED-PRINCIPAL REGISTER
- 05 Jan 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 04 Jan 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 Jan 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 10 Dec 2021 — USE AMENDMENT FILED
- 04 Jan 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Dec 2021 — TEAS STATEMENT OF USE RECEIVED
- 03 Jun 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Jun 2021 — SOU EXTENSION 4 GRANTED
- 01 Jun 2021 — SOU EXTENSION 4 FILED
- 01 Jun 2021 — SOU TEAS EXTENSION RECEIVED
- 25 Nov 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Nov 2020 — SOU EXTENSION 3 GRANTED
- 23 Nov 2020 — SOU EXTENSION 3 FILED
- 23 Nov 2020 — SOU TEAS EXTENSION RECEIVED